Skip to Content

E 801 E 801 (Rifampin 150 mg)

Pill imprint E 801 E 801 has been identified as Rifampin 150 mg.

Rifampin is used in the treatment of bartonellosis; tuberculosis, latent; nasal carriage of staphylococcus aureus; endocarditis; leprosy (and more), and belongs to the drug class rifamycin derivatives. Risk cannot be ruled out during pregnancy. Rifampin 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Rifampin 150 mg E 801 E 801 Front
Rifampin 150 mg E 801 E 801 Back
Rifampin 150 mg E 801 E 801
E 801
E 801
150 mg
18.00 mm
Prescription only
Drug Class:
Rifamycin derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
corn starch
D&C Yellow No. 10
docusate sodium
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
magnesium stearate
microcrystalline cellulose
sodium benzoate
propylene glycol
ferrosoferric oxide
magnesium silicate
titanium dioxide
D&C Red No. 28
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5472 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.